We've already written about the annual screening programme and what executive screening covers in earlier articles – this article focuses on a narrower question that concerns many people: which cancer screening is recommended from what age, for whom, and how does this fit into the framework of group health insurance? The aim is not medical advice, but to help both HR and employees make informed decisions about what's worth using from the package.
Why is this a separate topic within screening?
The protocols presented in our basic and executive screening article differ by duration and depth – this article instead takes a cross-cutting look at which specific cancer screening becomes particularly advisable when, by age and sex. This is useful because the screening allowance available in the package is often broader than what colleagues actually use – they simply don't know when it would be worth using it.
For women: breast and cervical screening
According to Hungarian and international professional recommendations, breast screening (mammography) typically becomes a regular topic from around age 40-45, while cervical screening (gynaecological cytology) is typically recommended from a younger age, at regular intervals – the exact starting age and frequency are set by the prevailing national screening protocol and by the treating doctor or gynaecologist. The precise frequency and entry age vary according to professional protocols and individual risk factors – such as family history – so it is always worth clarifying this with the treating doctor or gynaecologist; the package provides access, not a diagnosis.
For men: prostate screening
For men, prostate screening (typically a PSA blood test and a urology examination) is the element people talk about least, even though it's often the most neglected area in male colleagues' health. Professional recommendations typically suggest regular screening from age 50, or earlier where there is an elevated family risk. Packages' urology specialist examinations and lab diagnostics typically cover this too – the details are set out in the specific package description.
For both sexes: skin and colorectal screening
Dermatological mole screening is recommended annually, regardless of age, for anyone who spends a lot of time in the sun, has fair skin, or has a family history of skin cancer – it's one of the simplest, quickest examinations that packages' specialist allowance typically includes. Colorectal screening (typically a faecal occult blood test, and colonoscopy where indicated) becomes a prominent topic for those over 50, and many people put it off precisely out of concern about the discomfort involved – yet early detection is one of the factors that counts for the most here.
How does this fit into the package framework?
Depending on the package tier, these examinations can be taken up either as part of the annual screening programme or independently, within the open specialist/diagnostic allowance. The logic set out in our outpatient and diagnostic cover article applies here too: the specialist examination and the lab or imaging diagnostics that go with it form the core of the package, while the specific limits and frequency are set out in the contract, varying by package tier.
When the screening result isn't clear-cut
With cancer screening, most of the anxiety comes not from the examination itself but from the waiting and an uncertain result. If a finding isn't clear-cut, or a colleague wants reassurance before taking further steps, many packages can help here too: the service described in our second medical opinion article is designed exactly for this situation, where a diagnosis or a recommended treatment needs confirmation before the colleague makes a decision. This step is often worth at least as much as the screening itself – resolving the uncertainty is, in itself, a health gain.
HR's role: getting the information across
The biggest obstacle is typically not the lack of cover, but that colleagues don't know from what age, what's worth using. Well-timed internal communication – for example tied to the autumn screening-programme campaign, as our organisation checklist also suggests – can do a lot to boost participation. Good practice is for the campaign message not to talk about „health awareness" in general terms, but to specifically name which examination is relevant for which age group or sex – this prompts action far more effectively than a general call to action. It's important, though, that here too HR only draws attention to the opportunity: the health details, individual risk and the final decision remain, throughout, a matter between the colleague and their doctor – the company does not, and must not, have visibility into this.
A question about your own team? Book a free 20-minute consultation →
